
2026-02-11•Immunotherapy
CAR-T Therapy Can Be Merged With Antibody-Drug Conjugates
Solid tumors have resisted both CAR-T therapy and antibody-drug conjugates for different reasons. This study collapses that divide, engineering CAR-T cells that deliver chemotherapy directly within the tumor microenvironment.
CAR-T |Antibody-Drug Conjugates
